211 related articles for article (PubMed ID: 3883503)
1. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
[TBL] [Abstract][Full Text] [Related]
2. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
[TBL] [Abstract][Full Text] [Related]
3. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Morgan LR
Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
[TBL] [Abstract][Full Text] [Related]
4. A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
Buzdar AU; Jones SE; Vogel CL; Wolter J; Plourde P; Webster A
Cancer; 1997 Feb; 79(4):730-9. PubMed ID: 9024711
[TBL] [Abstract][Full Text] [Related]
5. Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
Buzdar AU; Smith R; Vogel C; Bonomi P; Keller AM; Favis G; Mulagha M; Cooper J
Cancer; 1996 Jun; 77(12):2503-13. PubMed ID: 8640699
[TBL] [Abstract][Full Text] [Related]
6. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
Buzdar AU; Jonat W; Howell A; Jones SE; Blomqvist CP; Vogel CL; Eiermann W; Wolter JM; Steinberg M; Webster A; Lee D
Cancer; 1998 Sep; 83(6):1142-52. PubMed ID: 9740079
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
Cobau CD; Declercq K; Neuberg D; Ingle JN; Tormey DC
Cancer; 1996 Feb; 77(3):483-9. PubMed ID: 8630955
[TBL] [Abstract][Full Text] [Related]
8. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
[TBL] [Abstract][Full Text] [Related]
11. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
Cruz JM; Muss HB; Brockschmidt JK; Evans GW
Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
[TBL] [Abstract][Full Text] [Related]
12. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
[TBL] [Abstract][Full Text] [Related]
13. Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
Benghiat A; Cassidy SA; Davidson HE; Mancero FS; Pickard JG; Tyrrell CJ
Eur J Surg Oncol; 1986 Mar; 12(1):43-5. PubMed ID: 3956753
[TBL] [Abstract][Full Text] [Related]
14. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
[TBL] [Abstract][Full Text] [Related]
15. Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.
Schrijver J; Alexieva-Figusch J; van Breederode N; van Gilse HA
Nutr Cancer; 1987; 10(4):231-45. PubMed ID: 3432093
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Pinelli DM; Fiorica JV; Roberts WS; Hoffman MS; Nicosia SV; Cavanagh D
Gynecol Oncol; 1996 Mar; 60(3):462-7. PubMed ID: 8774658
[TBL] [Abstract][Full Text] [Related]
17. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
[TBL] [Abstract][Full Text] [Related]
18. Oral versus im administration of high-dose medroxyprogesterone acetate in pretreated patients with advanced breast cancer.
Beex L; Burghouts J; van Turnhout J; Breed W; Hillen H; Holdrinet A; Boetius G; Hoogendoorn G; Doesburg W; Verhulst M
Cancer Treat Rep; 1987 Dec; 71(12):1151-6. PubMed ID: 3690524
[TBL] [Abstract][Full Text] [Related]
19. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
20. Clinical results with megestrol acetate in patients with advanced carcinoma of the breast.
Ansfield FJ; Kallas GJ; Singson JP
Surg Gynecol Obstet; 1982 Dec; 155(6):888-90. PubMed ID: 7147170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
